Insulin Price Caps, XIL Report Exposes Skyrocketing DIR Fees

Update: 2020-02-17

Description

Week of February 9, 2020

Comments

In Channel

FDA Approves Pharmacists to Perform COVID-19 Testing, Unanswered Questions...

2020-04-1302:09

States Address Drug Shortages, PBMs Slash Pharmacy Reimbursements In COVID-19 Pandemic

2020-04-0602:31

State Boards of Pharmacy Act Fast in Response to COVID-19

2020-03-3002:25

Pharmacy Organizations Unite To Push For Provider Status In Emergency COVID-19 Legislation

2020-03-2202:41

National Meetings Cancelled, Pharmacy Retailers Step Up In Response To Coronavirus Outbreak

2020-03-1602:37

Senate Passes Coronavirus Bill, Virginia Leads In Expanding Prescriptive Authority of Pharmacists

2020-03-0902:46

Associations Support PBM Supreme Court Case, White House Addresses Coronavirus, Flu Season 2021

2020-03-0203:08

US Supreme Court Takes On PBMs, FDA Announces Breakthrough Gene-Drug Interaction Tool

2020-02-2402:23

Insulin Price Caps, XIL Report Exposes Skyrocketing DIR Fees

2020-02-1702:38

PBM Reform, FDA Crackdown on Vaping

2020-02-1102:23

Medicaid Block Grants, Coronavirus, Drug Shortage Legislation

2020-02-0201:57

Tester Ep 1

2020-01-2801:55

00:00

#box-pro-ellipsis-175733728651627{-webkit-line-clamp:2;}Insulin Price Caps, XIL Report Exposes Skyrocketing DIR Fees